Back to Newsroom
Back to Newsroom

SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Xtant Medical Holdings Inc. (XTNT) and Encourages Investors with Losses to Contact the Firm

Friday, November 25, 2022 8:30 AM
Kaskela Law LLC

PHILADELPHIA, PA / ACCESSWIRE / November 25, 2022 / Kaskela Law LLC announces that it is investigating Xtant Medical Holdings Inc. ("Xtant") (NYSE:XTNT) on behalf of the Company's investors.

Since July 2021, shares of Xtant's common stock have declined in value from a trading price of $2.00 per share to a current trading price of less than $0.70 per share, a cumulative decline of over 65% in value.

The investigation seeks to determine whether Xtant and/or the company's representatives violated the securities laws by issuing false and/or misleading statements and/or failing to disclose material information to Xtant investors, thereby causing investor losses.

Xtant stockholders are encouraged to contact Kaskela Law LLC (Adrienne Bell, Esq.) at (484) 229 - 0750, or by email ([email protected]) or online at , for additional information about this investigation and their legal rights and options.

Kaskela Law LLC exclusively represents investors in securities fraud, corporate governance, and merger & acquisition litigation. For additional information about Kaskela Law LLC please visit This notice may constitute attorney advertising in certain jurisdictions.


D. Seamus Kaskela, Esq.
Adrienne Bell, Esq.
18 Campus Blvd., Suite 100
Newtown Square, PA 19073
(888) 715 - 1740
(484) 229 - 0750

SOURCE: Kaskela Law LLC

Class Action
Back to newsroom
Back to Newsroom